ANKH Activators refer to a class of chemicals that specifically engage with the biological pathway of the ANKH protein, a crucial regulator in the body's mineralization process. These activators are characterized by their ability to upregulate the expression or function of the ANKH protein, thereby influencing the balance of inorganic pyrophosphate (PPi) within extracellular environments. PPi is a molecule known for its role in controlling bone and crystal formation by modulating the deposition of calcium and other minerals. The mechanism by which ANKH Activators enhance the function of the ANKH protein can vary; some may interact directly with the protein's regulatory elements, while others may exert their effects indirectly through signaling pathways that converge on the gene's expression or the protein's stability and activity.
The chemical structures within this class can be diverse, reflecting the complexity of the biochemical systems they engage with. They might include small molecules, organic compounds, or ions that can traverse cellular membranes and reach the intracellular domains where ANKH resides. Given the protein's transmembrane nature, these activators often possess properties that allow them to be involved in the cellular trafficking of ions and molecules essential for maintaining the physiological balance between bone formation and resorption. The precise molecular interactions of ANKH Activators with their target sites are a subject of ongoing research, aiming to decipher the nuances of their binding affinities, their influence on the conformation of ANKH, and their impact on the protein's transport functions. These insights contribute to a broader understanding of mineral homeostasis at the cellular and systemic levels.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
May upregulate ANKH by enhancing osteoblast differentiation and bone formation processes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Could increase ANKH expression through hormonal regulation of bone density and remodeling. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Might upregulate ANKH by promoting calcium absorption and bone mineralization pathways. | ||||||
Corticosterone | 50-22-6 | sc-300391 sc-300391A | 100 mg 500 mg | $58.00 $110.00 | 2 | |
Could modulate ANKH expression through their effects on inflammation and bone metabolism. | ||||||
Calcitonin, Salmon | 47931-85-1 | sc-201167 sc-201167A | 1 mg 5 mg | $154.00 $625.00 | 1 | |
Might enhance ANKH expression by inhibiting bone resorption and promoting bone formation. | ||||||
Strontium Ranelate | 135459-87-9 | sc-208403 | 10 mg | $320.00 | ||
May induce ANKH expression by mimicking calcium and affecting bone metabolism. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Might enhance ANKH by stimulating new bone formation at low concentrations. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Could upregulate ANKH expression through the Wnt signaling pathway, which is involved in bone formation. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
May increase ANKH expression by acting as a recombinant form of parathyroid hormone, thus stimulating bone formation. | ||||||